JANIGA, MATTHEW M.D.
Urology · NPI 1891912259 · AUBURN, CA
JANIGA, MATTHEW is a Urology in AUBURN, CA, a member of 1 medical group, who billed 38 distinct codes to Medicare Part B in 2024.
Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | premium | premium | premium | premium |
| J9030 | Bcg live intravesical instillation, 1 mg | premium | premium | premium | premium |
| J0585 | Injection, onabotulinumtoxina, 1 unit | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 51798 | Ultrasound measurement of bladder capacity after voiding | premium | premium | premium | premium |
| 81003 | Automated urinalysis test | premium | premium | premium | premium |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | premium | premium | premium | premium |
| 51720 | Instillation of anti-cancer drug into bladder | premium | premium | premium | premium |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | premium | premium | premium | premium |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | premium | premium | premium | premium |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | premium | premium | premium | premium |
| 74420 | Imaging of urinary tract following injection of a contrast agent | premium | premium | premium | premium |
| 55700 | Biopsy of prostate gland | premium | premium | premium | premium |
| 51700 | Simple bladder irrigation and/or instillation | premium | premium | premium | premium |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | premium | premium | premium | premium |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | premium | premium | premium | premium |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | premium | premium | premium | premium |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| 76857 | Limited ultrasound scan of pelvis | premium | premium | premium | premium |
| 76942 | Ultrasonic guidance for needle placement | premium | premium | premium | premium |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | premium | premium | premium | premium |
| A4648 | Tissue marker, implantable, any type, each | premium | premium | premium | premium |
| 52240 | Destruction and/or removal of large growth of bladder using an endoscope | premium | premium | premium | premium |
| 55874 | Injection of biodegradable material next to prostate | premium | premium | premium | premium |
| 52001 | Irrigation and removal of multiple blood clots from bladder and urethra using an endoscope | premium | premium | premium | premium |
| 55876 | Placement of device in prostate for radiation therapy | premium | premium | premium | premium |
| 52281 | Dilation of urethra using an endoscope | premium | premium | premium | premium |
| 52318 | Crushing, fragmenting, and removal of bladder stones, more than 2.5 cm | premium | premium | premium | premium |
| 76872 | Ultrasound scan of pelvic region through rectum | premium | premium | premium | premium |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | premium | premium | premium | premium |
| 50590 | Shock wave crushing of kidney stones | premium | premium | premium | premium |
| 52332 | Insertion of stent in ureter using an endoscope | premium | premium | premium | premium |
| 52234 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | premium | premium | premium | premium |
| 52315 | Complicated removal of foreign body, stone, or stent in urethra or bladder using an endoscope | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.